SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$18,387
-42.9%
10,4470.0%0.00%0.0%
Q1 2023$32,177
-41.9%
10,4470.0%0.00%0.0%
Q4 2022$55,369
-90.9%
10,447
-81.2%
0.00%
-90.9%
Q4 2020$611,000
+4.1%
55,691
-15.8%
0.01%
-38.9%
Q3 2020$587,00066,1360.02%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$2,692,0001.92%
SILVERARC CAPITAL MANAGEMENT, LLC 380,606$982,0000.30%
Pentwater Capital Management LP 4,967,227$12,815,0000.15%
Atom Investors LP 55,827$144,0000.06%
Corton Capital Inc. 14,978$39,0000.04%
Forefront Analytics, LLC 23,370$61,0000.03%
Delphia (USA) Inc. 15,799$41,0000.03%
Advisory Services Network, LLC 259,571$670,0000.02%
Laurion Capital Management LP 545,700$1,408,0000.02%
MCF Advisors LLC 59,659$154,0000.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders